ARCHIVES

Severe Shortages Of Many Cancer Drugs Affecting Practices

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training

June 20, 1986

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990